The US Centers for Medicare and Medicaid Services will be pursuing an interesting and important package of drug pricing policy changes as it follows through on a White House executive order to expand the reforms incorporated in the 2022 Inflation Reduction Act.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?